España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Defiance Daily Target 2x Long MSTR ETF
MSTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$63.96
-4.72
-6.87%
At close: -
$63.68
-0.28
-0.44%
After Hours: Dec 27, 7:59 PM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Defiance Daily Target 2x Long MSTR ETF (NASDAQ:MSTX)
Defiance Daily Target 2x Long MSTR ETF (NASDAQ: MSTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 27, 2024
'Russian Nesting Doll' Of Problems: MSTX And DIPS Top Morningstar's Worst ETF List For 2024
Pooja Rajkumari
Tuesday, December 24, 2024
MicroStrategy ETFs Face Tracking Error Because Of Volatility: Here Are The Potential Risks Investors Face
Rishabh Mishra
Thursday, December 05, 2024
How Leveraged MicroStrategy ETFs Are Powering The Bitcoin Surge
Surbhi Jain
Wednesday, November 27, 2024
MicroStrategy-Linked ETFs Skyrocket 400% This Year: Is This 'The Michael Saylor Effect'?
Pooja Rajkumari
Thursday, November 21, 2024
Bitcoin Boom 2.0? MicroStrategy Gains Traction As 'Leveraged Bet' On Crypto Growth
Surbhi Jain
Wednesday, September 18, 2024
MicroStrategy 2X Leveraged, Inverse ETFs Are Here, Offer 'Unparalleled Access To MicroStrategy's Bitcoin Exposure'
Chris Katje
Thursday, August 22, 2024
Spot Bitcoin ETFs Will Soon Own More BTC Than Satoshi, Analysts Predict, But Another Fund Is The 'Most Volatile ETF Ever' In The US
Khyathi Dalal
MicroStrategy's Bitcoin 'Strategy Playbook' Explained: Will Others Follow This 'Radical Step'?
Khyathi Dalal
Thursday, April 20, 2017
Mast Therapeutics Reports Possible Adjournmen...
Benzinga
Monday, April 17, 2017
Mast Releases PR Asking For Stockholders To V...
Benzinga
Mast Therapeutics Offers Reminder Holders Vot...
Benzinga
Tuesday, April 11, 2017
Mast Therapeutics Reports ISS, Glass Lewis Re...
Benzinga
Monday, March 06, 2017
Mast Therapeutics Reports Q4 EPS $(0.02) vs $...
Benzinga
Mast Therapeutics Reports Clinical Study Agre...
Benzinga
Monday, January 09, 2017
The Market In 5 Minutes: Earnings Results, Conferences, Trump And More
Benzinga
Wall Street's M&A Chatter From January 6-8
Benzinga
Saturday, January 07, 2017
Mast Therapeutics, Savara Sign Merger Agreement; Deal Values Mast @$36.5M
Benzinga
Tuesday, December 06, 2016
Mast Therapeutics Announces Initiation Of Patient Enrollment In Additional Phase 2 Study Of AIR001 For The Treatment Of Heart Failure With Preserved Ejection Fraction
Benzinga
Tuesday, November 08, 2016
Mast Therapeutics Reports Q3 EPS $(0.04) vs. ...
Benzinga
Monday, October 17, 2016
Mast Therapeutics Reports Agreement With Philips For Supply Of Adaptive Aerosol Delivery System For AIR001
Benzinga
Tuesday, September 27, 2016
15 Biggest Mid-Day Losers For Tuesday
Benzinga
Mast Therapeutics Provides Clinical Developments Update; Range-Bound Trading A Mid-Term Plausibility
Benzinga
The Market In 5 Minutes: Debates, Oil Keep Stocks Mixed
Benzinga
Benzinga's Top Downgrades
Benzinga
Cowen & Co. Downgrades Mast Therapeutics to Market Perform
Benzinga
Monday, September 26, 2016
Mast Therapeutics Issues Business Update: Say...
Benzinga
Wednesday, September 21, 2016
Mid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings
Benzinga
12 Biggest Mid-Day Losers For Wednesday
Benzinga
Mid-Day Market Update: Crude Oil Up 2.75%; Mast Therapeutics Shares Drop After Sickle Cell Drug Phase 3 Trial Fail
Benzinga
Mid-Morning Market Update: Markets Open Higher; General Mills Earnings Top Views
Benzinga
20 Stocks Moving In Wednesday's Pre-Market Session
Benzinga
Tuesday, September 20, 2016
After-Hours Decliners Sept. 20, 2016: MSTX Do...
Benzinga
Shkreli Warned You: Mast Therapeutics Plummets 80% After Sickle Cell Drug Phase 3 Trial Fail
Benzinga
Mast Therapeutics Shares Down 80% in After-Ho...
Benzinga
UPDATE: Mast Expects To Terminate All Clinica...
Benzinga
Mast Therapeutics Reports Top-Line Results Fr...
Benzinga
Monday, September 19, 2016
Watch These 7 Huge Call Purchases In Monday Trade
Benzinga
Friday, September 16, 2016
Option Alert: MSTX Apr17 2.5 Calls Sweep: 720...
Benzinga
Tuesday, September 13, 2016
Shkreli Thinks The Mylan-Epipen Controversy Is 'Not Very Fair'
Benzinga
Monday, September 12, 2016
Martin Shkreli Thinks Jazz Pharmaceuticals Could Be Worth $20 Billion, While Mast Therapeutics Is 'Worthless'
Benzinga
UPDATE: Martin Shkreli on Short Opportunity i...
Benzinga
Martin Shkreli on Investor Opportunity in Pha...
Benzinga
Mast Therapeutics Releases Investor Presentation
Benzinga
Thursday, September 01, 2016
Watch These 7 Huge Call Purchases In Thursday Trade
Benzinga
Wednesday, August 31, 2016
Option Alert: MSTX Oct16 2.5 Calls Sweep: 500...
Benzinga
Thursday, August 18, 2016
11 Biopharma CEOs To Follow On Twitter
Benzinga
Tuesday, August 09, 2016
Mast Therapeutics Reports Q2 EPS $(0.05) vs. ...
Benzinga
Monday, August 01, 2016
Mast Therapeutics Reports Start Of Phase 2 Study Of AIR001 Conducted By The Heart Failure Clinical Research Network
Benzinga
Tuesday, July 26, 2016
15 Biggest Mid-Day Losers For Tuesday
Benzinga
15 Stocks Moving In Tuesday's Pre-Market Session
Benzinga
Show More